Financials

  • Market Capitalization 12.914 B
  • Employee 927
  • Founded 1989
  • CEO Brett P. Monia Ph.D.
  • Website www.ionis.com
  • Headquarter California, United States
  • FIGI BBG000JH6683
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-33.24
Price to sales ratio
Dividends per share
Dividend yield %

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.

Haberler